DiaMedica Inc. Announces Results of Annual General and Special Meeting of Shareholders
28 nov. 2016 19h00 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 28, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), today announced that at its Annual General and Special Meeting (the...
DiaMedica Establishes Neurological Scientific Advisory Board With Several Distinguished Experts
12 oct. 2016 07h30 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 12, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the establishment of a Scientific Advisory Board...
DiaMedica Announces First Patient Enrolled in Bridging Clinical Trial for DM199
05 oct. 2016 08h00 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 5, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced that the first patient has been dosed in the Phase Ib...
DiaMedica to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference
26 sept. 2016 08h00 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 26, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), a biopharmaceutical company developing novel treatments for...
DiaMedica Announces Regulatory Clearance to Initiate Bridging Clinical Trial for DM199
12 sept. 2016 08h00 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 12, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) DiaMedica announced that it has received regulatory clearance in...
DiaMedica Completes Second Tranche of Non-Brokered Private Placement With Hermed Capital
08 sept. 2016 13h51 HE
|
DiaMedica Inc.
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 8, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce that it has closed the...
DiaMedica Completes First Tranche of Non-Brokered Private Placement with Hermed Capital
22 août 2016 08h00 HE
|
DiaMedica Inc.
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - Aug. 22, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce that it has closed the...
DiaMedica Announces Strategic Investment by Hermed Capital Healthcare Fund
18 juil. 2016 00h30 HE
|
DiaMedica Inc.
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - July 17, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced a strategic investment with...
DiaMedica Announces U.S. Composition of Matter Patent for DM199
14 juin 2016 08h00 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - June 14, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the U.S. Patent and Trademark Office has issued...
DiaMedica Appoints Dr. Todd Verdoorn as Chief Scientific Officer
09 mai 2016 08h00 HE
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - May 9, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the appointment of Dr. Todd Verdoorn as the Company's...